Microbot Medical Inc. (MBOT) financial statements (2022 and earlier)

Company profile

Business Address 25 RECREATION PARK DR SUITE 108
HINGHAM, MA 02043
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15,49224,64831,2925,23810,7872,70912,111
Cash and cash equivalents13,49319,65028,7715,23810,7872,70912,111
Short-term investments1,9994,9982,521    
Restricted cash and investments87844,3582527 2,423
Receivables     606 
Prepaid expense      625
Deferred costs      1
Other current assets300521286568116  
Other undisclosed current assets      53
Total current assets:15,87925,25335,9365,83110,9303,31515,213
Noncurrent Assets
Operating lease, right-of-use asset644775962
Property, plant and equipment24425122825990535,218
Intangible assets, net (including goodwill)      46
Intangible assets, net (excluding goodwill)      46
Other noncurrent assets      743
Total noncurrent assets:8881,0261,19025990536,006
TOTAL ASSETS:16,76726,27937,1266,09011,0203,36821,219
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7061,1581,0791,3855287838,244
Accounts payable279275284630782012,512
Accrued liabilities1,4278837957554505825,732
Debt  143   1,437
Deferred revenue and credits  149
Other undisclosed current liabilities2781873,6043,375   
Total current liabilities:1,9841,3454,8264,7605287839,830
Noncurrent Liabilities
Long-term debt and lease obligation402626760  768,933
Long-term debt, excluding current maturities     768,917
Capital lease obligations   16
Operating lease, liability402626760
Liabilities, other than long-term debt   8283132,020
Deferred revenue and credits  1,651
Other liabilities      369
Derivative instruments and hedges, liabilities   828313 
Other undisclosed noncurrent liabilities(402)(626)   (783)771
Total noncurrent liabilities:402626760828(394)11,723
Total liabilities:2,3861,9715,5864,76855638921,554
Temporary equity, carrying amount    500500 
Stockholders' equity
Stockholders' equity attributable to parent, including:14,38124,30831,5401,3229,9641,696(334)
Common stock727272314062661,113
Treasury stock, value  (3,375)(3,375)(500)  
Additional paid in capital69,90268,51669,95432,53030,18214,465455,192
Accumulated other comprehensive income      47
Accumulated deficit(55,593)(44,280)(35,111)(27,864)(20,624)(13,035)(456,687)
Other undisclosed stockholders' equity attributable to parent    500  
Other undisclosed stockholders' equity     783 
Total stockholders' equity:14,38124,30831,5401,3229,9642,479(334)
TOTAL LIABILITIES AND EQUITY:16,76726,27937,1266,09011,0203,36821,219

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues      117
Gross profit:      117
Operating expenses(11,357)(9,089)(7,240)(7,244)5,2679,635(36,837)
Other undisclosed operating income (loss)   14,488(10,534)  
Operating income (loss):(11,357)(9,089)(7,240)7,244(5,267)9,635(36,720)
Nonoperating income (expense)   (14)  305
Foreign currency transaction loss, before tax   (14)   
Other nonoperating income      130
Interest and debt expense    2,322(28)(506)
Other undisclosed income from continuing operations before equity method investments, income taxes      73,336
Income (loss) before gain (loss) on sale of properties:(11,357)(9,089)(7,240)7,230(2,945)9,60736,415
Other undisclosed net income  14,4871010,534  
Net income (loss):(11,357)(9,089)7,2477,2407,5899,60736,415
Other undisclosed net income (loss) attributable to parent44(80)(14,494)(14,480)(15,178)(19,270)(72,830)
Net loss attributable to parent:(11,313)(9,169)(7,247)(7,240)(7,589)(9,663)(36,415)
Preferred stock dividends and other adjustments   (254)(1,582)3,954 
Other undisclosed net income available to common stockholders, basic  14,49414,48015,17811,418 
Net income (loss) available to common stockholders, basic:(11,313)(9,169)7,2476,9866,0075,709(36,415)
Interest on convertible debt    (237)(333) 
Net income (loss) available to common stockholders, diluted:(11,313)(9,169)7,2476,9865,7705,376(36,415)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(11,357)(9,089)7,2477,2407,5899,60736,415
Other undisclosed comprehensive loss      (72,848)
Comprehensive income (loss):(11,357)(9,089)7,2477,2407,5899,607(36,433)
Other undisclosed comprehensive loss, net of tax, attributable to parent (80)(14,494)    
Comprehensive income (loss), net of tax, attributable to parent:(11,357)(9,169)(7,247)7,2407,5899,607(36,433)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: